BAP Pharma Hosts Grand Opening Ceremony for Its New US Headquarters
May 01 2024 - 5:11AM
Business Wire
On Wednesday, 24th of April 2024 BAP Pharma hosted the Grand
Opening Ceremony for its new US headquarters in Somerset NJ.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240501437577/en/
Tom Skiendzielewski, General Manager of
BAP Pharma US making a commemorative speech at the Grand Opening
Ceremony of the company's new US headquarters in Somerset, NJ.
(Photo: Business Wire)
The weather could not have been better for an exciting day of
events as BAP Pharma welcomed guests and dignitaries to the Grand
Opening Ceremony of its new headquarters on Randolph Road.
In attendance were BAP Pharma executives and employees,
dignitaries including Mary Stahl, Head Key Accounts and Projects,
Life Sciences from the British Consulate General New York, and BAP
Pharma customers, both old and new.
Events started with a fully catered “Meet and Greet” followed by
guided facility tours by BAP Pharma executives and employees to
showcase BAP Pharma’s operations and the new and expanded features
and capabilities.
Commemorative speeches were given by Sara Sooy, Somerset County
Commissioner Deputy Director, Chris Edwards, Somerset County
Business Partnership, President & CEO, and Tom Skiendzielewski,
General Manager of BAP Pharma US. The speeches were followed by the
formal ribbon cutting by Mrs. Nafisa Parkar, BAP Pharma
Director.
Established in 2011 by Dr. Bashir Parkar, Founder and Managing
Director, BAP Pharma provides the high-quality supply of comparator
drugs for clinical trials to help overcome the common barriers to
treatment for patients. By providing a global solution as a
top-tier service provider, BAP Pharma delivers medicines to
patients at the right time, at the right place, and at the right
temperature.
Dr. Parkar stated, “We want to thank all our guests and
employees for joining us to celebrate such a significant day in the
history of BAP Pharma. With our continued, accelerated growth, our
investment into this new facility ensures that we have both the
capacity and the capabilities to provide the clinical trial
solutions our customers need, when and where they need them, giving
them the peace of mind that their clinical trials supplies will
never be critical path.”
BAP Pharma’s new US headquarters are fully licensed by the New
Jersey State Department of Health and are in a modern,
state-of-the-art 28,000 sq. ft. facility with capabilities that
include a 24-hour temperature-controlled and monitored warehouse
with ambient (+15°C to +25°C), cold (+2°C to +8°C), and freezer
(-20°C) storage facilities. Additionally, BAP Pharma’s new US
facility can provide in-house label design and print,
temperature-controlled clinical secondary packaging, and
just-in-time/on-demand labelling.
BAP Pharma recently formed two new divisions - “Clinical
Secondary Packaging & Labelling” and “Medicines Access” - to
complement the original “Comparator Sourcing” business,
necessitating the move to a much larger facility with a broader
range of capabilities.
BAP Pharma is a UK based, award-winning, global leader in the
clinical trials solution industry, specializing in comparator
sourcing, clinical secondary packaging/labelling, and medicines
access.
BAP Pharma has established a global reputation within the
industry as a reliable partner by building strong connections with
clients to gain their loyalty, and it now counts many of the
world’s largest names in pharmaceutical manufacturing as their
clients.
For more information on BAP Pharma please email
enquiries@bappharma.com or visit their website at
www.bappharma.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240501437577/en/
BAP Pharma Ltd. Ken Dobbie +44 (0)1753 924 768
Ken.Dobbie@bappharma.com